Research Article
Study on Risk Factors for Death from Cardiomyopathy and Effectiveness of Health Information Management
Table 1
Analysis of risk factors for death from cardiomyopathy.
| Indexes | Survival group | Death group | X2/t | |
| Age (years) | 62.41 ± 11.26 | 71.15 ± 15.82 | 4.174 | <0.001 | Baseline body mass (kg) | 61.94 ± 10.05 | 62.11 ± 10.08 | 0.111 | 0.912 | LVEF (%) | 32.01 ± 3.61 | 23.17 ± 2.04 | 8.863 | <0.001 | APACHEII | 15.14 ± 2.32 | 19.05 ± 3.31 | 5.357 | <0.001 | SOFA score | 7.38 ± 2.14 | 10.01 ± 3.19 | 3.858 | 0.002 | Myocardial enzymes (μ/l) | 31.74 ± 4.60 | 32.05 ± 4.55 | 0.444 | 0.657 | Troponin (ng/ml) | 0.12 ± 0.05 | 0.13 ± 0.04 | 1.448 | 0.149 | Infectious factors | | | 2.573 | 0.109 | Infected | 40 (55.56) | 11 (78.57) | | | Uninfected | 32 (44.44) | 3 (21.43) | | | History of heart disease | | | 2.273 | 0.132 | Y | 25 (34.72) | 2 (14.29) | | | N | 47 (65.28) | 12 (85.71) | | | Gender | | | 0.293 | 0.588 | Male | 26 (36.11) | 4 (28.57) | | | Female | 46 (63.89) | 10 (71.42) | | |
|
|